Roche & Genentech
Huckman recommends keeping a eye on Roche and Genetech. As you may know Genentech shares rose Friday after a published report said Swiss drugmaker Roche was preparing to sweeten its offer to buy the portion of the U.S. biotechnology giant it does not already own.
The Financial Times' Alphaville web site said Roche was preparing to offer about $95 per share, likely ahead of its release of its year-end financial report in early February.
If the deal happens, Roche could win billions of dollars in cancer drug revenue as well as strong R&D. And both are presenters at the conference.
Pete Najarian speculates the current offer might not be enough.
Other Names To Watch
According to Huckman this conference has really made its reputation on small cap biotechs. He thinks investors should look for bio-medical diamonds in the rough.
And the best way to play it is with the SPDR S&P Biotech , or iShares NASDAQ Biotechnology Index, explains Karen Finerman.
In addition, Huckman also thinks there could be news out of Genzyme , Celgene and Amgen three other presenters. They could re-affirm their guidance, or provide color on Q4 revenue which would, in turn, move their stocks, he says.
Got something to to say? Send us an e-mail at email@example.com and your comment might be posted on the Rapid Recap. If you'd prefer to make a comment but not have it published on our website send your e-mail to firstname.lastname@example.org.
Trader disclosure: On Jan 9, 2009, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Najarian Owns (CSCO), (DNA); Najarian Owns (XME) Calls, (NVLS) Calls, (NVDA) Calls; Najarian Owns (EEM) Long Call Spread ;Najarian Owns (ERTS) Long Call Spread; Karabell Owns (AAPL), (CL), (DRYS), (GOOG), (JPM), (NOK); Seymour Owns (AAPL), (BAC), (EEM), (F), (TSO); Seymour's Firm Owns (PBR); Finerman's Firm Owns (DSX), (MSFT), (DNA); Finerman's Firm Is Short (IYR), (IJR), (IWM), (MDY), (SPY), (USO), (ANF), (AEO), (BBT); Finerman's Firm Is Long (MSFT) Put Spreads